Effects of Purified Omega-3 Fatty Acids on Serum Lipoproteins and Malondialdehyde in Postmenopausal Fat Women Receiving Hormone Replacement Therapy

Shidfar F; Keshavarz A; Jalali M; Miri R; Amri A; Shidfar SH

International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

Current Issue All Issues In Press Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Effects of Purified Omega-3 Fatty Acids on Serum Lipoproteins and Malondialdehyde in Postmenopausal Fat Women Receiving Hormone Replacement Therapy

Author(s):

Shidfar F^1,*,

Keshavarz A², Jalali M

Jalali M¹,

Miri R³,

Amri A¹,

Shidfar SH⁴

1School of Health, Iran University of Medical Sciences, farzadshidfar@yahoo.com, IR Iran

2School of Public Health, Tehran University of Medical Sciences, IR Iran

3Shaheed Beheshti University of Medical Sciences

4dMemorial Hospital, University of Massachusetts, USA

International Journal of Endocrinology and Metabolism:Vol. 2, issue 2; 87-94

Published online:Sep 01, 2004

Article type:Research Article

How to Cite:Shidfar FKeshavarz AJalali MMiri RAmri AShidfar SHet al.Effects of Purified Omega-3 Fatty Acids on Serum Lipoproteins and Malondialdehyde in Postmenopausal Fat Women Receiving Hormone Replacement Therapy.Int J Endocrinol Metab.2(2):87-94.

Abstract

Introduction:

Regular intake of n-3 fatty acids of marine origin have desirable effects on serum lipoproteins and reduce coronary vascular disease (CVD). n-3 fatty acid supplementation decreased serum triglyceride concentrations in studies in which most of the subjects were male. The effects of n-3 fatty acids supplementation in fat women especially postmenopausal fat women have received little attention. The aim of this study was to determine whether purified n-3 fatty acids have desirable effects on serum lipoproteins, malondialdehyde (MDA) and lipoprotein risk factors for CVD in postmenopausal fat women receiving hormone replacement therapy (HRT).

Materials and Methods:

In a double-blind, placebo-controlled trial of parallel design, 35 postmenopausal women receiving hormone replacement therapy were randomly allocated to receive 2 g purified n-3 fatty acids or placebo for 10 weeks. Serum lipoproteins and MDA were determined on days 0 and 70.

Results:

Serum levels of triglycerides (TG) decreased significantly in the n-3 fatty acids group at the end of study compared to the initial values, and also compared to control group (26%, p< 0.003 and 29%, p< 0.01, respectively)_In the n-3 fatty acids group, serum levels of TG/HDL-C decreased significantly at the end of the study compared to initial values and, at the end of the study, compared to control group as well (23 %, P

Conclusion:

Supplementation with purified n-3 fatty acids can favorably influence selected CHD risk factors, particulary by achieving marked reduction in serum TG and TG/HDL-C levels in postmenopausal fat women receiving HRT.

Keywords

Full Text

Full text is available in PDF

comments